In addition, one MPNST case displayed ATRX protein loss and was ALT-positive in the primary, and also displayed ATRX protein loss and was ALT-positive in 3 additional distant metastases, suggesting that ATRX loss and ALT are maintained during tumor progression. This evidence concerns the gene ATRX and malignant peripheral nerve sheath tumor.